메뉴 건너뛰기




Volumn 879, Issue 21, 2011, Pages 1893-1898

Quantitation of desmosine and isodesmosine in urine, plasma, and sputum by LC-MS/MS as biomarkers for elastin degradation

Author keywords

Biomarker; Chronic obstructive pulmonary disease; Elastin degradation; LC MS

Indexed keywords

ACCURATE MEASUREMENT; ANALYTICAL PROCEDURE; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; ELASTIC TISSUES; ELASTIN DEGRADATION; HEALTHY CONTROLS; IN-VIVO; INTERNAL STANDARDS; LC-MS; LC-MS/MS; MATRIX; NORMAL CONTROLS; PYRIDINOLINE; REPRODUCIBILITIES; SPUTUM SAMPLES; STANDARDIZED METHODS; TRANSITION IONS;

EID: 80052958371     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2011.05.011     Document Type: Article
Times cited : (71)

References (39)
  • 30
    • 80955179848 scopus 로고    scopus 로고
    • Desmosine and Isodesmosine analysis as possible biomarkers for COPD has been among the topics of two recent FDA workshops (2009 and 2010 at Bethesda): (a) G.M. Turino, Y.Y. Lin, Desmosine and isodesmosine as biomarkers of elastin degradation in COPD and Alpha-1 antitrypsin deficiency, FDA Study Group on " Improving Endpoints, Improving Care: Alpha-1 Antitrypsin Augmentation Thera
    • Desmosine and Isodesmosine analysis as possible biomarkers for COPD has been among the topics of two recent FDA workshops (2009 and 2010 at Bethesda): (a) G.M. Turino, Y.Y. Lin, Desmosine and isodesmosine as biomarkers of elastin degradation in COPD and Alpha-1 antitrypsin deficiency, FDA Study Group on " Improving Endpoints, Improving Care: Alpha-1 Antitrypsin Augmentation Therapy and Clinical Trials" Center for Biologics Evaluation and Research, FDA, Bethesda, Maryland, March 23-24, 2009; (b) M. Svartengren, M. Anderson, Hallberg, N. Pedersen (Karolinska Institutet Stockholm); P. Wollmer (Clinical Physiology Malmö University Hospital, Malmö Sweden); A. Dirksen, S. Shaker (Gentofte University Hospital, Hellerup, Denmark); C. Lindberg, K. Forsman-Semb, A. Lloyd (Astra-Zeneca Respiratory and Inflammation Clinical and Discovery Groups); G.M. Turino, Y.Y. Lin (James P. Mara Center for Lung Disease, St. Luke's-Roosevelt Hospital Centre); I. Kilty, N. Thompson, C. Palmer (Pfizer), F. Gervais, Boutinn et al. (Merk & Co), Study Group on " Desmosine and Isodesmosine as Biomarkers for COPD" FDA, Bethesda, Maryland, January 26-27, 2010.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.